The Centre’s decision to restrict over-the-counter sales of cough syrups is a positive step, but systemic weaknesses in India’s drug regulatory framework continue to undermine effective oversight
The WHO has identified three contaminated syrups made in India — including Coldrif, tied to child deaths in Madhya Pradesh — and warned they could cause life-threatening illnesses. The flagged products include syrups from Sresan, Rednex and Shape Pharma.
Ranganathan, owner of Tamil Nadu-based Sresan Pharma, was arrested by Madhya Pradesh police with Chennai assistance in connection with adulterated Coldrif cough syrup linked to multiple child deaths. Authorities seized documents and are investigating hygiene and labelling lapses at his factory
